2026-01-28 - Analysis Report
**Report on Netflix (NFLX)**

**Company Overview**
Netflix is a global streaming media and entertainment services company.

**Return Rate Comparison**

* Cumulative return of review stock (NFLX): 207.66%
* Cumulative return of comparison stock (S&P 500, VOO): 128.51%
* Divergence: 80.50 (relative divergence: 42.20%)

The cumulative return of Netflix is higher than that of the S&P 500, with a divergence of 80.50.

**Alpha, Beta Analysis**

| Year | CAGR | MDD | Alpha | Beta | Cap(B) |
|------|------|------|-------|------|-------|
| 2016-2018 | 76.0% | 40.9% | 67.0% | 1.6 | 113.4B |
| 2017-2019 | 47.0% | 40.9% | 22.0% | 1.7 | 137.1B |
| 2018-2020 | 54.0% | 40.9% | 30.0% | 0.9 | 229.1B |
| 2019-2021 | 47.0% | 32.4% | -17.0% | 0.8 | 255.3B |
| 2020-2022 | -70.0% | 74.6% | -74.0% | 1.0 | 125.0B |
| 2021-2023 | -67.0% | 74.6% | -85.0% | 1.5 | 206.3B |
| 2022-2024 | 155.0% | 62.3% | 126.0% | 1.5 | 377.7B |
| 2023-2025 | 183.0% | 30.0% | 107.0% | 1.1 | 397.3B |

The company's historical returns show a significant fluctuation in performance, with periods of high returns followed by periods of decline.

**Recent Stock Price Fluctuations**

* Close: $85.58
* Last-market: {'price': 85.58, 'previousClose': 85.7, 'change': -0.14}
* 5-day SMA: $85.26
* 20-day SMA: $89.17
* 60-day SMA: $98.98

The current stock price is slightly lower than the previous close, with the 5-day and 20-day SMAs below the current price.

**RSI, PPO Index Indicators and Delta_Previous_Relative_Divergence**

* Market Risk Indicator (MRI): 0.70
* RSI: 29.24
* PPO: 0.02
* Hybrid Signal: Buy (Cash 0%)
* Risk Level: Medium

The RSI and PPO indicators suggest a strong downtrend, with the RSI at a low level and the PPO indicating a sell signal.

**Recent News & Significant Events**

* 'It Hardly Matters,' Says Investor About Netflix Stock - TipRanks
* Should You Buy Netflix Stock After Its 36% Plunge? - The Motley Fool
* Netflix, Visa and 7 Other U.S. Stocks to Ride the International Stock Rally - Barron's
* Netflix, Meta upgraded: Wall Street's top analyst calls - Yahoo Finance
* Netflix Stock Is Living a Nightmare. Why It Just Got Upgraded. - Barron's
* Needham Advises Buying Netflix (NFLX) Weakness Despite $275M Regulatory Costs - Yahoo Finance

These recent news articles suggest that the company is facing challenges and that analysts are divided on its potential.

**Analyst Opinions**

Analyst Consensus:
- Key: Buy
- Mean (1=StrongBuy~5=Sell): 1.93 (~Buy)
- Opinions: 40
- Target Price (avg/high/low): 111.92 / 151.40 / 79.00

The analyst consensus is to buy the stock, with a mean opinion of 1.93 and a target price of $111.92.

**Recent Earnings Analysis**

| Date | EPS | Revenue |
|----|---:|---:|
| 2025-10-22 | 6 | 11.51 B$ |
| 2025-07-18 | 7.35 | 11.08 B$ |
| 2025-04-18 | 6.76 | 10.54 B$ |
| 2024-10-18 | 5.52 | 9.82 B$ |
| 2025-10-22 | 5.52 | 9.82 B$ |

The company's recent earnings have been strong, with revenue increasing and EPS fluctuating.

**Revenue and Profitability**

| Quarter | Revenue | Profit Margin |
|---------|----------|---------------|
| 2025-09-30 | $11.51B | 46.45% |
| 2025-06-30 | $11.08B | 51.93% |
| 2025-03-31 | $10.54B | 50.08% |
| 2024-12-31 | $10.25B | 43.71% |

The company's revenue has been increasing, with a profit margin of 46.45% in the latest quarter.

**Capital and Profitability**

| Quarter | Equity | ROE |
|---------|---------|-----|
| 2025-09-30 | $25.95B | 9.81% |
| 2025-06-30 | $24.95B | 12.53% |
| 2025-03-31 | $24.03B | 12.03% |
| 2024-12-31 | $24.74B | 7.55% |

The company's equity has been increasing, with a return on equity (ROE) of 9.81% in the latest quarter.

**Comprehensive Analysis (Summary of previous items)**

Netflix is a highly volatile company with a strong growth potential. The recent news and analyst opinions suggest that the company is facing challenges, but that analysts are divided on its potential. The company's financials show a strong revenue growth and increasing equity, but with a declining ROE. The RSI and PPO indicators suggest a strong downtrend, but the analyst consensus is to buy the stock. Overall, the company's performance is uncertain and requires further analysis.

**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.